Induction of specific gene expression may provide an alternative or a support to conventional cytotoxic chemotherapy of cancer, as well as to therapy for sickle cell diseases. In this respect, pharmacological induction of expression of the endogenous ␥-globin gene is a realistic approach to therapy of ␤-globin disorders. Erythroid differentiation and inhibition of proliferation of the human CML K562 cell line was induced by guanosine 5′-triphosphate (GTP). The hemoglobin production in cells was correlated to an increase in ␣-and ␥-globin mRNA expression. At the transcriptional level, we showed that both the expression of the major erythroid transcription factor GATA-1 (protein and mRNA) and its binding capacity to the ␥-globin gene promoter was transiently increased. Moreover, GTP moderately stimulated the ␥-globin gene promoter after 48 h of treatment. At the post-transcriptional level, GTP treatment led to a drastic increase of the ␥-globin mRNA half-life. This stabilizing effect of GTP was mediated via the 3′-untranslated region (3′-UTR) of the ␥-globin mRNA. In conclusion, mechanism of GTP-mediated differentiation of K562 cells is linked to an early activation of ␥-globin gene transcription followed by a stabilization of its mRNA. Leukemia (2000) 14, 1589-1597.
Introduction
Induction of specific gene expression may provide an alternative or a support to conventional cytotoxic chemotherapy of cancer, as well as to therapy for sickle cell diseases. 1, 2 In this respect, therapeutic strategies for different types of leukemia aim at inducing differentiation and apoptosis as well as growth inhibition. In this context, some antileukemic agents such as all-trans retinoic acid (ATRA), 3, 4 1-␤-D-arabinofuranosylcytosine (Ara-C) 5, 6 and hydroxyurea (HU) 7, 8 are clinically used. HU is also the only ribonucleotide reductase inhibitor in clinical use for the treatment and management of sickle cell anemia 9 and sodium butyrate is a differentiation inducer under investigation as a potential therapy for the treatment of sickle cell disease, as well as prostate cancer. 10, 11 Pharmacological induction of the endogenous ␥-globin gene expression is a realistic approach to therapy of ␤-globin disorders.
12, 13 Russell et al 14 showed that human embryonic globins could fully substitute for adult globins and reverse the hemolytic anemia and abnormal erythrocyte morphology of mice with nonlethal forms of ␣-and ␤-thalassemia.
The human CML K562 cell line was established by Lozzio and Lozzio in 1975 15 from the pleural effusion of a patient in blast crisis. These malignant cells are blocked in their normal maturation at an early stage of differentiation since they exhi- bit granulocytic, megakaryocytic and erythroid features. 16 They have been extensively used as an in vitro model for the study of the erythroid differentiation and the molecular mechanisms involved in differentiating agents activity. Numerous differentiating agents such as hemin 17 anthracyclines, [18] [19] [20] phenylacetate, 21 5-azacytidine ribonucleoside 22 and butyric acid, 23, 24 induce the erythroid differentiation of the human K562 cell line by increasing fetal globin gene expression. Moreover, it was recently shown that non-toxic concentrations of guanine, guanosine and guanine-nucleotides, induced the expression of erythroid phenotype in the human K562 cells as efficiently as the inducers previously mentioned. 25 But among them, guanosine 5′-triphosphate (GTP) led to the highest rate of hemoglobin-producing cells with an antiproliferative activity. The expression of embryonic hemoglobin types, Gower 1 ( 2 ⑀ 2 ) and Portland ( 2 ␥ 2 ), was increased and the ␥-globin mRNA was shown to be abundantly expressed after 7 days of treatment. Osti et al 25 proposed that the treatment of human bone marrow cells with GTP and related compounds might be an alternative to producing an increase in hemoglobin F in ␤-thalassemia patients. Our goal was to determine whether the GTP differentiating activity resulted from a transcriptional and/or a post-transcriptional molecular mechanism. In this study, we established a correlation between the time-course of hemoglobin producing K562 cells and the expression of the ␥-globin mRNA in GTPtreated cells. The effect of GTP on ␥-globin gene expression was assessed in K562 cells studying: (1) the ␥-globin gene promoter activity by transient transfections; (2) the expression of the major transcription factor GATA-1 involved in the regulation of the ␥-globin gene transcription; 26 and (3) the half-life of ␥-globin mRNA; as well as (4) the role of its 3′-untranslated region (3′-UTR). Our results demonstrate that GTP differentiating activity resulted from both transcriptional and posttranscriptional events on ␥-globin gene regulation in K562 cells.
Materials and methods

Cell culture and drug treatments
The human chronic myeloid leukemia (CML) K562 cell line and the human erythroleukemia cell line HEL, were cultured in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum, 2 mm l-glutamine, 100 UI/ml penicillin G and 100 mg/ml streptomycin in 5% CO 2 humidified atmosphere at 37°C. Erythroid differentiation was induced by the addition of 100 m GTP (Sigma Chemical Co, St Louis, MO, USA) to the cell suspension at the beginning of the exponential growth phase. Medium and GTP 100 m were renewed after 3 days of cell culture. Sterile aqueous solution of GTP at 10 mm was stored at −20°C and was freshly diluted in culture medium immediately before use. Erythroid differentiation was scored Leukemia by benzidine staining as previously described. 20 To determine mRNA stability, cells were treated for 6 days in the presence or absence of GTP before addition of 5 g/ml actinomycin D (Sigma Chemical Co).
RNA analysis
Total RNA was isolated from treated or non-treated K562 cells with GTP using Trizol reagent (Life Technologies, Nazareth, Belgium). For studying mRNA stability, extractions were performed after 8, 16, 24 and 30 h of transcription inhibition with actinomycin D. RNA preparations were submitted to reverse transcriptase (RT) according to the standard procedure using oligo(dT) primers, after the elimination of remaining genomic DNA by digestion with DNase. The RT products were used as templates for PCR amplification using ␣-32 P-dCTP and genespecific primers of ␥-globin (sense: 5′-GGCAACCTGTCC TCTGCCTC-3′; antisense: 5′-GCCAGGAAGCTTGCACCTCA-3′), ␣-globine (sense: 5′-TGGGGTAAGGTCGGCGCGCA-3′ ; antisense: 5′-TGCACC GCAGGGGTGAACTC-3′), 27 and GATA-1 (sense: 5′-GATCCT GCTCTGGTGTCCTCC-3′; antisense: 5′-ACAGTTGAGCAAT GGGTACAC-3′). The amount of cDNA synthesized was calibrated by using the relative expression level of the human glutaraldehyde-3-phosphate dehydrogenase gene mRNA (GAPDH) as standard. PCR was performed with primers specific for the GAPDH (sense: 5′-CTCTGCCCCCTCTGCT GATGC-3′; antisense 5′-CCAT-CACGCCACAGTTTCCCG-3′) by using a series of dilutions of cDNA synthesized from known amounts of total RNA. The PCR amplification efficiency for each pair of primers was determined empirically by checking the amounts of the PCR product on agarose gels after various cycles to maintain amplification in a linear range. Comparison of the relative levels of the different specific RNAs was then possible by RT-PCR analysis. Polyacrylamide gel electrophoreses were dried and submitted to autoradiography.
Western blot analysis
5 × 10 5 cells were lysed in Laemmli sample buffer and immediately boiled for 5 min. Protein concentration was determined using the BioRad (Hercules, CA, USA) protein assay method and 60 g protein was loaded on a 10% SDSpolyacrylamide gel. Separated proteins were then transferred on to a nitrocellulose membrane (Hybond C; Amersham, Roosendaal, The Netherlands). Membrane was pretreated for 1 h with 5% dry milk containing Tris-buffered saline and incubated overnight with an anti-GATA-1 monoclonal antibody (CS-265; Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a final concentration of 1 g/ml. After washing with 0.05% Tween 20-containing Tris-buffered saline, the membrane was incubated for 1 h with horseradish peroxidase antirat IgG conjugate (Amersham), and the immunoreactive proteins were visualized using the enhanced chemiluminescence system (Amersham). Purified recombinant human GATA-1 protein was used as a positive control.
Nuclear protein extraction and electrophoretic mobility shift assay (EMSA)
Nuclear proteins from 4 × 10 6 cells, differentiated or not, were prepared according to Schreiber et al, 28 in the presence of protease inhibitors (pepstatin, leupeptin, O-phenanthrolin and phenylmethylsulfonyl fluoride). In vitro binding capacity to their consensus sequences and electrophoretic runs were performed as previously described by Mantovani et al. 29 Sequence of the DNA oligonucleotide used in this experiment (top strand) was the fragment of the human ␥-globin promoter from −201 to −156: 5′-CCTTCCCCACACTATCTCAATGC AAATATCTGTCTGAAACGGTCCC-3′. The fragment was 32 Plabelled at the 5′-end with T4 polynucleotide kinase and ␥- 
Reporter gene constructions and transient transfections
In order to study the effect of GTP on the ␥-globin gene promoter activity, preparation of reporter constructs was performed as previously described 19 by subcloning the ␥-globin promoter of 0.33-kb (−299/+35) in the HindIII restriction site of pGL2-basic plasmid (Promega, Charbonnières, France) upstream of the luciferase reporter gene (LUC).
To study the role of the 3′UTR of the ␥-globin mRNA in its GTP-mediated stabilization, a construction was performed as followed: the non-coding region of the ␥-globin cDNA, 30 obtained by submitting total RNAs from K562 cell extracts to reverse transcriptase, was amplified using PCR. SacI restriction site-containing primers were used, sense: 5′-GGA ATT CGA GCT CGC CTC TTG CCC ATG ATT CAG-3′; antisense: 5′-GGA ATT CGA GCT CTG TGA TCT CTC AGC AGA ATA G-3′ (SacI site underlined) and the 88-bp cDNA region (+8546/+8634) was first subcloned into a pCRII-Topo plasmid (Invitrogen). The insert were digested by SacI (Gibco-BRL, Merelbeke, Belgium) according to the standard procedure, purified and introduced within the SacI restriction site downstream of the LUC reporter gene in the pSV2luc⌬3′UTR plasmid (Promega). The pSV2luc⌬3′UTR plasmid was obtained by deletion of the 3′UTR of the luciferase gene from pSV2luc as described in Figure 1 . The coding region of luciferase gene was amplified by using HindIII and SacI restriction sites-containing primers, sense: 5′-AAG CTT ATT CCG GTA CTG TTG GTA AA-3′; antisense: 5′-GAG CTC TTA CAA TTT GGA CTT TCC GC-3′ (HindIII and SacI sites, respectively, are underlined).
2 × 10 5 K562 or HEL cells were transfected by the transferrinfection method according to the instructions of the manufacturer (Bender, Vienna, Austria) with 3 g of luciferase construct and 3 g of ␤-galactosidase expressing control plasmid pCMV␤-gal (Clontech, Levsden, The Netherlands). Briefly, transferrin receptor expression was induced in the K562 membrane by adding desferrioxamin in culture medium for 20 h. Cells were then grown to early log phase, plotted and resuspended in serum-free RPMI medium at 1 × 10 6 cells/ml. Following 48 h and 72 h of incubation in 2.5 ml preheated complete medium, cells were harvested and resuspended in 300 l of lysis buffer (Promega). Light emission resulting from luciferase activity was measured in a luciferase assay buffer (Promega) using a luminometer (Promega) by integration of peak light emission over 15 s at 25°C. ␤-galactosidase activities were measured from 50 l of the supernatant in an assay buffer (Promega) by using Bradford assay (BioRad reagent, Ivry/Seine, France).
Figure 1
Construction procedure of the pSV2Luc-3ЈUTR glob plasmid.
Results
Effect of GTP on the erythroid differentiation of K562 cells
K562 cells in exponential growing phase were incubated with or without 100 M GTP over 6 days. Medium and GTP were renewed on the third day of treatment. The effect of GTP on erythroid differentiation and cell proliferation was studied. The hemoglobin cell content was shown by using the benzidine test. As shown in Figure 2 , GTP 100 m exerted a differentiating effect on these cells in a time-dependant manner. The rate of hemoglobin-producing cells reached 70% on the sixth day of treatment. There, the cell pellets exhibited an intensive red pigmentation. The differentiating effect was accompanied by a growth inhibition estimated at 60% after 6 days of treatment as shown in Figure 2 . By contrast, neither the erythroid differentiation nor the cytostatic effect was detectable in the human erythroleukemia cell line HEL using a range of concentrations of GTP (20-100 m) (data not shown).
Globin mRNAs overexpression in differentiated cells
The expression of the ␥-globin mRNA was then studied in a 6-day time-course experiment. Total RNAs were extracted from K562 cells at different times of differentiating induction and were submitted to RT-PCR analysis as described in Materials and methods using ␥-globin gene specific primers ( Figure 3 ). The ␣-globin mRNA expression was only studied on the sixth day of treatment. The results showed that ␥-globin mRNA expression strongly increased in GTP-induced K562 cells with time. This accumulation appeared as early as the second day of treatment in correlation with the benzidine time-course ( Figure 2) . Indeed, compared to the control value, a maximum of a three-fold increase was observed after a 6-day GTP treatLeukemia ment when the rate of hemoglobin-producing cells was maximum. During the same period of treatment, mRNA expression of the multistage development ␣-like gene, ␣-globin, was also significantly increased.
␥-Globin promoter activation
The effect of GTP on the ␥-globin gene promoter activity was then examined in K562 cells. The ␥-globin promoter was inserted upstream of the luciferase reporter gene (LUC) in a pGL2-basic plasmid according to Aries et al. 19 The construct Leukemia was named pGL2-␥-prom. Cells were transfected using the transferrinfection technique as described in Materials and methods. Cells transfected or not with pGL2-basic or pGL2-␥-prom were induced to differentiate with 100 m GTP for 48 h. LUC activity expressed in light units (LU) was normalized to the activity of the cotransfected ␤-galactosidase. Results showed that ␥-globin gene promoter was activated in K562 cells in the presence of 100 m GTP since the LUC activity was approximately 1.5-fold higher in treated cells compared to control cells (Figure 4) . GTP had no effect on LUC activity in cells transfected with the pGL2-basic plasmid. HEL cells were transiently transfected as a negative control with the pGL2-basic plasmid and with pGL2-␥-prom. No LUC signal was detectable in HEL-transfected cells whatever the plasmid used. Promoter of ␥-globin gene was activated only in the GTP-responsive K562 cells. This was a significant and sufficient stimulation to suggest that ␥-globin overexpression occurred via a transcriptional regulation during the first 48 h of GTP treatment.
The possibility that desferroxamine and other treatments involved in transferrinfection may affect differentiating activity of GTP was checked. Benzidine staining performed in cells submitted to the transferrinfection procedures showed that the induction of differentiation by GTP 100 m was not affected.
GATA-1 transcription factor expression
Since the ␥-globin gene promoter was activated by GTP, we investigated the effect of 100 m GTP on the major erythroidtranscription factor GATA-1 involved in the regulation of the erythroid genes expression. The ␥-globin gene promoter contains specific binding sites for this transcription factor. As described above, total RNAs were extracted after 2, 3, 4 and 6 days of GTP treatment and were analyzed using RT-PCR. As shown in Figure 5a , GATA-1 mRNA level was transiently increased. Indeed, a 2.8-fold increase was observed after 72 h of treatment and was followed by a progressive decrease until the sixth day.
Likewise, the GATA-1 protein expression and its binding activity to ␥-globin gene promoter showed a transient augmentation. Western blots were performed as described in Materials and methods using a monoclonal antibody directed
Figure 3
Detection of gene expression by RT-PCR analysis. K562 cells were induced to differentiate with 100 m GTP. Total RNA was extracted and submitted to reverse transcriptase for each time point indicated. RT products were used as templates for PCR amplification in the presence of ␣-32 P-dCTP by using gene specific pairs of primers for ␥-globin, ␣-globin and GAPDH. The relative expression level of GAPDH was used as an internal control. Results shown are representative of three independent experiments. against human GATA-1 protein. This antibody appeared to recognize a single band with an apparent M r of 50 000 in K562 cell extracts, corresponding to the purified recombinant GATA-1 protein. 20 According to the GATA-1 mRNA expression, the signals on immunoblots were transiently increased as shown in Figure 5b . The increase was 3.5-fold higher than in control and reached a peak at 96 h of treatment.
In addition, the GATA-1 binding activity on its specific DNA sequence in the ␥-globin promoter was studied using electrophoretic mobility shift assay. As previously described, 29 the −201 to −156 region of the human ␥-globin gene promoter contains two binding sites for the erythroid transcription factor GATA-1 and one site for the ubiquitous transcription factor OTF-1. Nuclear protein extracts were prepared as described in Materials and methods from K562 cells induced or not induced to differentiate over 6 days. The pattern obtained consisted mainly of three different bands (Figure 5c ). 31 The most retarded band was identified as OTF-1 since this binding complex disappeared by using an unlabeled human immunoglobulin (Ig) competitor oligonucleotide containing the OTF-1 binding site. The medium one corresponded to the DNA-GATA-1 complex since it strongly decreased by adding unlabeled mouse ␣-1-globin oligonucleotide which contains the GATA-1 sequence as a competitor. The minor band with the highest mobility has not yet been identified. Compared to non-induced cells, GATA-1 binding capacity was strongly increased upon GTP induction as early as the second day of treatment with a maximum intensity at 72 h. Blot analysis quantified using a phosphor-imager (BioRad) revealed a 3.5-fold increase of the GATA-1 binding capacity. A loss in the binding activity occurred after 96 h. In contrast, the intensity of the ubiquitous transcription factor OTF-1 binding remained unchanged, thus indicating the erythroid specificity of this activating process.
Figure 4
Transient transfection assays were performed in K562 cells using the pGL2basic or pGL2-␥-prom plasmids. GTP 100 m was added immediately after transfection and its effect on the ␥-globin gene promoter activity was estimated by measuring the luciferase expression after 48 h. pCMV-␤gal plasmid was cotransfected as an internal control. Results are the means of three independent experiments; s.d. are indicated.
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␥-Globin mRNA stability
Considering that 48 h of GTP treatment induced a moderate activation of the ␥-globin promoter in K562 cells, and that overexpression of GATA-1 transcription factor was followed by a dramatic decrease, we examined the possibility that the accumulation of ␥-globin mRNA may also be the result of its stabilization. The half-life of ␥-globin mRNA was determined by incubating cells with a non-cytotoxic concentration (5 g/ml) of the RNA polymerase inhibitor, actinomycin D. Preliminary experiments showed that actinomycin D, up to 10 g/ml, had no effect on viability and differentiation of K562 cells (data not shown). Total RNAs were extracted at 2, 8, 16, 24 and 30 h following actinomycin D addition to noninduced or induced K562 cells with 100 m GTP over 6 days. The decay of ␥-globin mRNA was analyzed by RT-PCR. The quantification of amplified cDNA signals was allowed by submitting blots to molecular imager analysis (BioRad). As shown in Figure 6 , the half-life of the ␥-globin mRNA in non-induced cells was about 25 h according to the literature. 32 After 6 days of GTP treatment, the relative half-life was significantly increased since it reached about 80 h. Therefore, change in the steady-state level of ␥-globin mRNA in GTP-treated cells resulted from a drastic stabilization.
We were then interested in determining whether the 3′-untranslated region (3′UTR) of the ␥-globin mRNA was involved in the GTP stabilizing effect. Total RNA extracts from K562 cells were reverse-transcribed and the 3′-non-coding region of the ␥-globin DNA was amplified using PCR. This region was then subcloned in the pSV2luc⌬3′UTR plasmid as described in Figure 6a and the construct was named pSV2luc-3′UTRglob. The identity of the amplified fragment to the published sequence 30 and its orientation in the plasmid was confirmed by sequencing. K562 cells were transiently transfected with the pSV2luc⌬3′UTR or with the pSV2luc-3′UTRglob plasmids. Immediately, they were treated or not with 100 m GTP for 48 h and 72 h. In all cases, the pCMV␤-gal plasmid was cotransfected as an internal control. The luciferase (LUC) activity was evaluated as a function of time in transfected cells; results are presented in Figure 7 . In each experiment the LUC activity at the 48th h, reported by ␤-gal expression, was determined as 100%. In cells transfected with the pSV2luc and treated or not with GTP, the LUC expression rates at 72 h were 64% ± 6.5 and 67% ± 8, respectively, in accord with a loss of the reporter gene activity transiently transfected. Similar results were obtained with cells transfected with pSV2luc (data not shown). In untreated cells transfected with the pSV2luc-3′UTRglob construct the relative LUC expression remained similar (68% ± 8.5). In contrast, in GTP-treated K562 cells and transfected with pSV2luc-3′UTRglob, the ratio was 98% ± 6.2. This suggested that the decay of the LUC expression in cells containing the chimerical LUC-3′UTRglob mRNA and treated with GTP, was slower and detectable for a longer period of time in the cells.
Discussion
We studied the molecular mechanism of erythroid differentiation induced by exogenous guanosine 5′-triphosphate (GTP) in the human chronic myeloid leukemia K562 cells. The present data indicate that GTP induces hemoglobin synthesis and a loss of self-renewal capacity in a time-dependent manner. This phenomenon proves to be specific to K562 cells since no hemoglobin was detectable in the HEL cell line what-
Leukemia
Figure 5
Effect of GTP 100 m on the transcription factor GATA-1 in the K562 cells induced to differentiate for 6 days. Blots are representative data of at least three independent experiments. (a) Detection of GATA-1 gene expression by RT-PCR analysis. Total RNA was extracted and submitted to reverse transcriptase for each time point indicated. RT products were used as templates for PCR amplification in the presence of ␣-32 P-dCTP by using gene specific pairs of primers for GATA-1 and GAPDH. The relative expression level of GAPDH was used as an internal control. (b) Analysis of GATA-1 protein level in GTP-treated cells was performed by Western blotting using a monoclonal antibody directed against human GATA-1. Total proteins extracts were prepared for each time indicated. (c) Bandshift data of the binding activity of the GATA-1 transcription factor to the ␥-globin gene promoter region (−201 to −156) from K562 cell nuclear extracts.
ever the GTP concentration in a time-course experiment. We showed that the hemoglobin synthesis in K562 cells was correlated to a significant increase in the expression of ␥-globin and ␣-globin mRNAs which are both components of the fetal hemoglobin (HbF: ␣ 2 , ␥ 2 ). In addition, the differentiating effect of GTP was previously reported as associated with an increase in embryonic Portland and Gower 1 hemoglobins. 25 Such observations were consistent with a process of commitment
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Figure 6
Stability of ␥-globin mRNA in GTP-treated cells. Cells were grown for 6 days in medium alone (control) or in the presence of 100 m GTP. (a) Total RNAs were isolated 8, 16, 24 and 30 h after actinomycin D addition (5 g/ml) and submitted to reverse transcriptase. RT products were used as templates for PCR amplification in the presence of ␣-32 P-dCTP by using gene specific pairs of primers for ␥-globin and GAPDH. The relative expression level of GAPDH was used as an internal control. (b) Signals on blot were quantified using a GS363 molecular imager (BioRad). Results were plotted as a linear regression of the means of three independent experiments in order to evaluate the relative half-life of ␥-globin mRNA; s.d. are indicated.
to terminal differentiation. Therefore, the capacity of GTP to modulate the expression of globin genes in K562 cells raised into question the molecular basis for the mechanism of regulation. It has been widely reported that the high-level expression of the different ␣-like and ␤-like globin genes requires both transcriptional 33, 34 and post-transcriptional regulation. [35] [36] [37] [38] Numerous differentiating inducers of leukemia cells have been shown to regulate the expression of differentiation-associated genes via transcriptional mechanisms. Indeed, we previously reported that the anthracycline, aclarubicin, induced an increase in the rate of globin gene transcription in K562 cells. [18] [19] [20] Similar results were obtained in these cells after hemin treatment 39 and in MEL cells with hexamethylene bis-acetamide and butyrate. 40 In this work, we studied the consequences of GTP treatment on the activity of the ␥-globin gene promoter in K562 cells transiently transfected with the pGL2-␥-prom plasmid. A moderate activation was observed 48 h following transfection. Though moderate, this activation has to be taken into consideration due to the slow effect of GTP as an erythroid differentiating agent. Indeed, the rate of benzidine-positive cells was less than 20% after 48 h of treatment with 100 m GTP and 6 days were necessary to reach 70%. In addition, ␥-globin promoter was not activated in HEL cells which do not differentiate in the presence of GTP. These facts suggested that GTP might exert its differentiating activity by stimulating ␥-globin gene transcription for at least 48 h. Pharmacological inducers of HbF in K562 cells such as aclacynomicin 31 and sodium butyrate 41 have been shown to increase the expression of transcription factors such as the zinc finger protein GATA-1, as well as the basic leucin zipper protein NF-E2. In addition, a recent work 42 showed that a fungus-derived compound (OSI-2040) induced ␥-globin transcription in K562 cells in correlation with the enhancement of the helix-loop-helix (HLH) transcription factor Id2. At the transcriptional level, the erythroid specific transcription factor GATA-1 has been shown to play a central role in the control of erythroid gene promoters. [43] [44] [45] Sequences conforming to the consensus [(A/T)GATA(A/G)] and corresponding to the major erythroid DNA-binding protein, ie GATA-1, are present in the promoter of numerous erythroid-expressed genes including
Figure 7
The pSV2luc-3′UTRglob construct, as well as the control plasmid pSV2luc⌬3′UTR were transiently transfected in K562 cells for 48 h and 72 h in the absence or presence of GTP 100 m. GTP was added immediately after transfection. In all cases luciferase activity after 72 h of transfection assays is indicated as a percentage of the one after 48 h. The Luc activities at 48 h were normalized to the ␤-galactosidase cotransfected expression (pCMV␤-gal plasmid) and arbitrarily determined as 100%. Results are the means of three independent experiments; s.d. are indicated.
globin genes 33 and GATA-1 itself; 46 in addition, they are distributed throughout the core regions of all LCR elements. 47 Convincing evidence for the central role of GATA-1 in regulating erythropoiesis has been provided by disrupting this locus via homologous recombination. 48 GTP induced a transient increase in the erythroid transcription factor GATA-1 including mRNA and protein. This fact was correlated to a transient increase in the binding of GATA-1 to its specific site in the ␥-globin promoter region, while the rates in hemoglobinized cells, as well as the ␣-and ␥-globin gene expression increased until the sixth day of treatment. The protein phosphorylation as a regulation process for its DNA binding should not be excluded. Indeed, significant increase in GATA-1 binding activity after differentiation induction of K562 cells by hemin, sodium butyrate or Trichostatin A was shown to be ascribable to a phosphorylation of the protein. 49 However, immunoblot analysis revealed unchanged levels of GATA-1 protein after induction by the above differentiating agents by contrast to the GTP effect. On the other hand, Boyes et al 50 reported that GATA-1 acetylation in vitro and in vivo directly stimulated GATA-1-dependent transcription.
Following the decrease in GATA-1 expression, we observed a drastic increase of the ␥-globin mRNA stability on the sixth day of treatment. Likewise, hemin and dimethyl sulfoxide were shown to increase the stability of globin, as well as ferrochelatase mRNAs in the murine erythroleukemia cell line (MEL) 51, 52 and doxorubicin stabilized the porphobilinogen deaminase mRNA in correlation with the erythroid differentiation of the K562 cells. 20 In contrast, a destabilizing process has been described in K562 cells during the switch from Leukemia erythroid to megakaryocytic gene expression by phorbol ester, leading to a marked decrease in the half-life of globin mRNAs. 53 In our experiments, the relative half-life of the ␥-globin mRNA was approximately 25 h in K562 cells whereas it was about 80 h in GTP-treated cells. This process seems to mimic the physiological one: the globin mRNAs enrichment in terminally differentiated erythroid cells in spite of a global and progressive silencing of gene transcription involving unknown mechanisms; 54 this event is accompanied by a drastic increase in globin mRNAs half-life estimated between 16 and 60 h in different reports. [35] [36] [37] 55 This high stability allows for globin transcript accumulation over more than 95% of the total cellular mRNA in terminally differentiated erythrocyte precursors. 56 Numerous general and specific cis-elements are involved in the message stability of mRNAs. [57] [58] [59] [60] Studies of globin mRNA stability showed the existence of regulatory sequences and ribonucleoprotein complexes in the 3′-UTR of the very stable ␣-and ␤-globin mRNAs. 44, [61] [62] [63] The regulation of ␥-globin mRNA stability has not actually been studied yet; but it was shown elsewhere that megakaryocytic differentiation of K562 cells induced by phorbol myristate acetate was correlated to the destabilization of ␥-globin mRNA and paralleled by the appearance of 3′ cleavage products. 64 This suggested a potential cleavage-site protection by protein in stable ␥-globin mRNA. We therefore hypothesized an implication of the 3′-UTR in the stabilization of this mRNA by GTP in K562 cells. To answer this question we used a reporter construct and transient transfections in order to lead the cells to express the chimerical LUC-3′UTRglob mRNA. It is known that a particular mRNA can accumulate in cells following a stabilization unless a modification of the transcription occurs. In GTP-mediated differentiation of K562 cells expressing the chimerical mRNA, the LUC activity did not decrease after 72 h and remained the same as it was after 48 h of transient transfection. This suggested that GTP exerted its differentiating activity on K562 cells by increasing ␥-globin mRNA stability via its 3′-UTR. In contrast, the chimerical mRNA was not stabilized in non-induced cells suggesting the induction of RNAbinding proteins as regulatory factors by GTP.
Taken together these results demonstrated that GTP induced erythroid differentiation in K562 cells both by a partial activation of ␥-globin gene transcription and a post-transcriptional mechanism. The induction of gene expression by pharmacological agents by targeting transcriptional and post-transcriptional regulation should be considered to differentiate cancer cells, as well as to induce apoptosis in order to develop a transcriptional therapeutic strategy.
